Data and Information

Abbott has received clearance from the FDA for its imaging software that uses artificial intelligence to provide doctors a better view of blood flow and blockages in heart vessels.

AI algorithms will inform treatment decisions by recognising patterns of data from past treatments.

This marks the fourth clearance for Volpara’s breast health platform since its original authorization back in 2010.  

Doctors are dealing with information overload, but tech could help. 

The companies will combine their complementary pathology tools to leverage services for tech-enabled diagnostics, drug discovery and patient care.   

Clinical communication tool used in the NHS saved patient photos on smartphones.

The programme, which is focused on providing preventive and personalised healthcare for citizens of the United Arab Emirates, wants more citizens to offer samples.

From drug discovery to forecasting kidney disease AI could be the next game-changer in healthcare. 

The new capital boosts Olive’s valuation to $4 billion.  

The “first of its kind” institution aims at enhancing local genomic research, and diagnosing and treating patients with genetic disorders. Its launch coincides with the formation of the board of the Emirati Genome Program.